Zobrazeno 1 - 10
of 19
pro vyhledávání: '"He-Gen Li"'
Autor:
Congcong Wang, Ling Xiao, Ling Gao, Jia Wu, Siliang Wang, Miao-Miao Zheng, Chen-Tai Qin, Xian-ge Huang, Lei Zhou, Wei-jie Xu, He-gen Li, Wen-Lian Chen, Li-hua Zhu, Xing Jin
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39859- (2024)
Mounting evidence strongly indicates that exosomes are pivotal in the advancement of cancer, yet the overarching profile of exosomal proteins and their contribution to lung adenocarcinoma (LUAD) progression remain underexplored. In our investigation,
Externí odkaz:
https://doaj.org/article/94cf84f22a864e0b97af2e521d1a5d94
Publikováno v:
Chinese Journal of Integrative Medicine. 27:490-495
To investigate the effects of multidisciplinary and comprehensive Chinese medicine (CM) treatments on progression-free survival (PFS) and median survival time (MST) in patients with advanced non-small cell lung cancer (NSCLC) and identify factors tha
Background: Non-small cell lung cancer (NSCLC) is the most common malignant tumor in lung. In this study, we aimed to explore the role and underlying mechanism of circular RNA 0018534 (circ_0018534) in NSCLC progression.Methods: Real-time quantitativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8481dc5651680daf5d5bcb9e52d10925
https://doi.org/10.21203/rs.3.rs-764297/v1
https://doi.org/10.21203/rs.3.rs-764297/v1
Autor:
Ai-qin Gu, Yi Jiang, Li-Ping Shen, Jia-Xiang Liu, He-cheng Li, Qi Li, Gening Jiang, Pin-xian Huang, Ling-Shuang Liu, He-gen Li
Publikováno v:
Clinical Lung Cancer. 20:e541-e547
Adjuvant chemotherapy (AC) has been proven to yield an approximately 5% improvement in 5-year survival for patients with early-stage non-small-cell lung cancer. With such small gains in survival, the optimal treatment regimen remains to be establishe
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine
Background Metastasis is the main cause of lung cancer death. As a seed of metastasis, circulating tumor cells are an important target for metastasis intervention. The traditional Chinese medicine, Jinfukang, has been clinically available for the tre
Autor:
Yan Li, He-gen Li, Bin Luo, Zujun Que, Chen-Tong Wang, Fangfang Qian, Yi Jiang, Xianghui Han, Jianhui Tian, Jia-Xiang Liu
Publikováno v:
Journal of ethnopharmacology. 256
Ethnopharmacological relevance Jinfukang has long been used for the clinical treatment of lung cancer. Previous studies have shown that Jinfukang can induce the apoptosis of circulating tumor cells by intervening ROS-mediated DNA damage pathway. Howe
Autor:
Jia-Liang Yao, Hong-Xi Xu, Zujun Que, Bin Luo, Pan Yu, He-gen Li, Jia-Xiang Liu, Zhi-yi Zhou, Jianhui Tian
Publikováno v:
Journal of Ethnopharmacology. 275:114175
Ethnopharmacological relevance Circulating tumor cells (CTCs) play an important role in tumor metastasis and may be a target for metastasis prevention. The traditional Chinese medicine Jinfukang functions to improve immunity, prevent metastasis, and
Autor:
Huai-Min Liu, Jianhui Tian, Li-Hua Zhu, Wen-Ji Shang-Guan, Zujun Que, He-gen Li, Yun Yang, Pan Yu, Hai-Tao Liu
Publikováno v:
Journal of Ethnopharmacology. 267:113473
Ethnopharmacological relevance Metastasis is the main cause of death in lung cancer patients. Circulating tumor cells (CTCs) may be an important target of metastasis intervention. Previous studies have shown that Jinfukang could prevent the recurrenc
Autor:
Qing Wang, Yi Jiang, Jianwen Liu, Yu Jin, Bing Hu, Zhi-yi Zhou, Changsheng Dong, Bin Luo, Lin Wang, Zujun Que, Jianhui Tian, He-gen Li, Hui Shi
Publikováno v:
Journal of integrative medicine. 16(4)
Objective Escape from the body’s immune response is a basic characteristic of lung cancer, and indoleamine-2,3-dioxygenase (IDO) plays a key role in mediating immune escape of non-small-cell lung cancer, which leads to recurrence and metastasis. Fe
Autor:
Zhu-Jun Mao, Yi Yang, Hai Huang, He-gen Li, Xiaolin Jin, Jianli Sun, Yi Jiang, Changsheng Dong, Lijing Jiao, Xiaoyong Shen, Lei Zhang, Ling Xu, Zhiwei Chen, Jiaming Che, Yabin Gong, Jia-Xiang Liu, Jianfang Xu, Peiqi Chen
Publikováno v:
Scientific Reports
The aim was to evaluate the effects of traditional Chinese medicine (TCM) as a combination medication with adjuvant chemotherapy on postoperative early stage non-small cell lung cancer (NSCLC) patients. The 314 patients with completely resected stage